Investor Centre

Summit is publicly-listed in the UK (LSE) and US (NASDAQ)

Regulatory News

Summit Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
VIEW NEWS
Summit Awarded Additional $12 Million by BARDA for Phase 3 Development Programme of Ridinilazole for the Treatment of C. difficile Infection
VIEW NEWS

Share Price

LSE: SUMM
At 26/09/2018 07:37
LSE: SUMM
At 26/09/2018 07:36